Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-19-034240

Options or other derivatives

  • EVP, Chief Scientific Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sepp-Lorenzino Laura · EVP, Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…